
PO63 : Optimizing Prostate Cancer Treatment in Men with
2023年9月1日 · As a successor to the largest randomized clinical trial (ASCENDE) comparing low-dose-rate prostate brachytherapy (LDR-PB) boost to external beam radiation therapy (EBRT) boost for prostate cancer (PCa) treatment, this study is designed to continue the use of the LDR-PB boost that resulted in high levels of biochemical progression-free survival (...
PO-63 - Exhausted platelets in cancer patients with ... - ScienceDirect
2016年4月1日 · In a prospective observational cohort study of cancer patients we measured pre-chemotherapy platelet P-selectin and glycoprotein (GP) IIb/IIIa expression and monocyte-platelet aggregates (MPA) in vivo and in response to ex vivo stimulation of the platelet activation receptors protease-activated receptor (PAR) -1, -4, and GPVI by whole blood flow...
PO-63 - Exhausted platelets in cancer patients with high risk
Results: Out of 62 patients (median age [interquartile range, IQR]: 63 [54-70] years, 48% female) with cancers of the pancreas (n=19), lung (n=18), brain (n=14), colon (n=8) and stomach (n=3), 9 (14.5%) developed VTE and 32 (51.6%) died.
PO-63 - Exhausted platelets in cancer patients with ... - Semantic …
DOI: 10.1016/S0049-3848(16)30196-7 Corpus ID: 11646612; PO-63 - Exhausted platelets in cancer patients with high risk of venous thromboembolism and poor prognosis. @article{Riedl2016PO63E, title={PO-63 - Exhausted platelets in cancer patients with high risk of venous thromboembolism and poor prognosis.}, author={Julia A Riedl and Alexandra Kaider and Christine Marosi and Gerald W. Prager and ...
PO-63 - Exhausted platelets in cancer patients with high risk of …
Platelets play a crucial role in cancer development, progression and metastatic spread of malignancy. In vitro data show that cancer cells have the ability to activate platelets, and clinical studies found increased levels of platelet activation markers in cancer patients. Moreover, platelets are thought to be involved in the development of venous thromboembolism (VTE) in cancer patients, a ...
PO-63 - Exhausted platelets in cancer patients with high
2016年4月1日 · Materials and Methods In a prospective observational cohort study of cancer patients we measured pre-chemotherapy platelet P-selectin and glycoprotein (GP) IIb/IIIa expression and monocyte-platelet...
PO-63 - Exhausted platelets in cancer patients with high
2016年4月8日 · In a prospective observational cohort study of cancer patients we measured pre-chemotherapy platelet P-selectin and glycoprotein (GP) IIb/IIIa expression and monocyte …
Car Check TAX & MOT history report for PO63 W**
Free Tax & MOT vehicle check report for PO63 W** registered in Preston between 1 September 2013 in 28 February 2014. Check the history of PO63 W...
P63
P53家族成员,标记多种上皮的基底细胞,胸腺瘤中的上皮样成分 (+),标记肌上皮及其肿瘤。 表达于鳞状上皮及尿路上皮的基底层和乳腺、前列腺、涎腺基底细胞。 胞核. 与PAX8联用用于肾集合管癌与尿路上皮癌的鉴别诊断。 商品化试剂(排名不分先后,本网站对抗体质量不负责!
PO63 - ScienceDirect
2023年9月1日 · As a successor to the largest randomized clinical trial (ASCENDE) comparing low-dose-rate prostate brachytherapy (LDR-PB) boost to external beam radiation therapy (EBRT) boost for prostate cancer (PCa) treatment, this study is designed to continue the use of the LDR-PB boost that resulted in high levels of biochemical progression-free survival (...
- 某些结果已被删除